Event Preview | Meet EClinCloud at the China Forum on Skin Diseases and Transdermal Drug Delivery Research and Development

Source: EClinCloud. Author: EClinCloud.

On November 19, 2023, the China Forum on Skin Diseases and Transdermal Drug Delivery Research and Development, themed "Technology-Empowered, Illuminating Medical Research," will be held at the Beijing Renwei Hotel. Discussions will focus in depth on clinical research topics in skin diseases—such as alopecia, psoriasis, and atopic dermatitis—and transdermal drug delivery.
The forum will bring together experts from research universities and institutes, prominent clinical investigators, leading investment firms, top pharmaceutical R&D companies, and innovative technology platforms to discuss project initiation, study design, regulatory policy, clinical design, clinical execution, translational medicine, and commercialization for skin diseases and transdermal drug delivery, exploring the competitive landscape and how to break through in the future.
Date
November 19, 2023
Location
19 Panjiayuan Nanli, Chaoyang District, Beijing
Dr. Qin Long, Founder and CEO of EClinCloud, has been invited to attend and will deliver a keynote presentation titled "Electronic Collection of Endpoint Assessment Data in Dermatology", as well as participate in a panel discussion on future-oriented scientific strategies for topical drugs.
EClinCloud's clinical endpoint assessment solutions span various therapeutic areas, and the company has also accumulated extensive experience in scale copyright management and electronic scale data collection in dermatology.

Dr. Qin Long
EClinCloud | Founder & CEO
Over 17 years of experience in technology applications for the clinical research industry;
An innovative and inspiring leader, and a pioneer in promoting and implementing eCOA, EDC, CTMS, and other technology solutions in clinical trial research in China;
Previously served as Asia-Pacific head at several international technology companies, leading rapid regional business growth;
An entrepreneur driven by academia and science, passionately dedicated to shaping new models for future clinical trials.
Note
✦
To register for the conference, please follow the "Guoxin Pharmaceutical Technology (国信医药科技)" WeChat Official Account
Get the Full Conference Agenda
EClinCloud is a technology company focused on clinical R&D, offering an integrated, interconnected all-in-one cloud platform for clinical trials (including solutions across technology products and offerings such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, covering scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) as well as clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system, ophthalmology, etc.). By combining cutting-edge technology with life data, EClinCloud builds a globally leading, "patient-centric" clinical evidence support SaaS cloud platform to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



